Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease (PL-10, PLD-116, PL 14736, Pliva, Croatia)
10.1016/j.survophthal.2019.01.011 13 CudeiroJ.RivadullaC., and (1999)
Dosage, Concentration, Route of Administration Dosage: Seek advice from a licensed physician, medical director, or other healthcare provider Concentration: 100mg/mL Route of administration: IV/IM/SubQ Resources: Tutorial: How to Give a Subcutaneous Injection Tutorial: How to Give an Intramuscular Injection Tutorial: How to Open Your Medication Vial NAD+ Injection Dosage Chart Storage Store compounded NAD+ injections under refrigeration and keep protected from light
Symptoms include hives, urticaria, facial swelling, and in severe cases, anaphylaxis
Split timing is based on short rat half-life data, not a proven human benefit